Spots Global Cancer Trial Database for MicroRNA as Markers in Testicular Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: MicroRNA as Markers in Testicular Cancer
Official Title: MicroRNA-371 as Markers for Disease Activity and as a Tool to Monitor the Effect of Chemotherapy and Early Detection of Recurrence in Patients With Testicular Germ Cell Tumours
Study ID: NCT04914026
Interventions
Study Description
Brief Summary: The main objective of this study is establish the performance of miR371 in management of testicular cancer
Detailed Description: The main objective of the study is to asses the sensitivity and specificity of microRNA-371a-5p (miR371) in detection of viable testicular germ tumour cells. To assess the utility of miR371 at orchiectomy, during treatment and surveillance and in early detection of recurrence.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Haukeland University Hospital, Bergen, , Norway
Haugesund Hospital, Haugesund, , Norway
Oslo University Hospital, Oslo, , Norway
University Hospital of North Norway, Tromsø, , Norway
Sahlgrenska University Hospital, Göteborg, , Sweden
Karolinska University Hospital, Stockholm, , Sweden
Contact Details
Name: Mette Pernille Myklebust, PhD
Affiliation: Haukeland University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
